You are here
Dr Anna Sureda
Dr Anna Sureda is Consultant in Haematology University Hospital Barcelona, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain. Dr Sureda graduated with a degree in Medicine in 1990. In 1991 she joined the Clinical Haematology Division of the Department of Haematology at Hospital de la Santa Creu i Sant Pau in Barcelona where she was appointed Head of the Outpatient Department in 2002. In January 2011, Dr Sureda moved to Cambridge University Hospital in Cambridge, UK, Addenbrookes Hospital, where she was appointed Senior Consultant in Lymphomas and Stem Cell Transplantation. In January 2013, she moved back to Barcelona where she is working as responsible physician of the Onco-Hematology Unit of the Haematology Department in Hospital Universitari Quiron Dexeus. She has more recently joined the Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain. She was a Visiting Physician at the University of Heidelberg, Germany in 1990 for four months and at the Fred Hutchinson Cancer Research Center of Seattle in 1993 for another period of four months.
Dr Sureda’s primary focus is on clinical investigations into the treatment of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma and multiple myeloma patients evaluating novel therapies such as immunotherapy combined with stem-cell transplantation and the analysis of the results and prognostic factors of autologous and allogeneic stem cell transplantation in lymphoid malignancies. She has participated in many phase II and III clinical trials for lymphoma patients. As a result of part of her clinical investigations, she achieved her PhD with the work entitled “Autologous Stem Cell Transplantation in Patients with Hodgkin’s Lymphoma” in June/2008.
Dr. Sureda has been an active member of the Spanish Cooperative Group of Lymphomas and Haematopoietic Stem Cell Transplantation (GELTAMO) since 1993 and during her stay in UK she was elected active member of the NCRN Lymphoma Study Group. In April/2004 she was appointed Chairperson of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and is presently the Secretary of EBMT.
She is a regular reviewer for the journals Blood, Annals of Oncology, Bone Marrow Transplantation, The Hematology Journal, The European Journal of Hematology and Annals of Hematology and has been co-authored more than 250 peer-reviewed journal articles.